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Abstract Dyschromatosissym-
metricahereditaria (DSH) is one 
of a group of reticulate pigment 
disorders of the skin. It is a rare 
autosomal dominantly inherited 
genodermatosis, presenting as 
mottled admixtures of hypopig-
mented and hyperpigmented 
macules on the dorsa of the ex-
tremities. It is predominantly 
found among persons of Oriental 
origin. We hereby document the 
first case of dyschromatosissym-
metricahereditaria in a four year 
old Nigerian boy who presented 
with progressive symmetric 
dyschromic lesions on the dorsa of 
the hands and feet, with no family 
history of similar lesions. The di-
agnosis was confirmed by the typi-
cal histologic finding of basal hy-
perpigmentation with normal num-
ber of melanocytes and absence of 








Dyschromatosissymmetricahereditaria (DSH) (aka.  
Reticulate acropigmentation of Dohi) is a rare genoder-
matoses which was first described in Japan1and has been 
more widely reported among Asian populations2-4. There 
have also been few reports among Caucasians and in 
some Middle Eastern countries5-7. It presents with as-
ymptomatic symmetrical reticular admixtures of hyper-
pigmented and hypopigmented macules on the dorsa of 
the hands and feet, and sometimes with freckle-like 
macules on the face. The condition usually starts in in-
fancy or childhood and progressively increases until 
adolescence when it stops spreading. Various therapeu-
tic agents have been employed in the treatment of this 
condition including topical steroids, calcipotriol and 
psoralen plus UVA (PUVA), but none has been effec-
tive. This report aims to acquaint clinicians on the exis-
tence of DSH in Nigeria, thus increasing the list of dif-
ferential diagnoses of pigmentary disorders in our envi-





A four year old boy of the Igbo tribe in South-eastern 
Nigeria was brought by an overtly anxious mother to the 
paediatric dermatology clinic of the University of Cala-
bar Teaching Hospital (UCTH)with a history of progres-
sively increasing symmetrical mottled hypopigmented 
and hyperpigmented lesions on the dorsa of both hands 
and feet which started when he was one year old.  There 
was no associated pruritus, localized abnormality of 
sweating, neither was there contact with any 
melanotoxic chemicals nor any preceding inflammatory 
skin disorder such as pityriasis alba, pityriasisliche-
noideschronica or psoriasisin the affected area prior to 
the appearance of the pigmentary changes.  The lesions 
were limited to the dorsa of the hands and feet, did not 
affect the palms, soles, face, axilla, trunk or mucous 
membrane. (Figure 1) There were no similar lesions in 
parents, siblings or other known family members andhe 
is the product of a non-consanguinous marriage. His 
delivery was normal, with attainment of normal devel-
opmental milestones. There were no other systemic 
symptoms, no evidence of photosensitivity, and his gen-
eral health was good with a weight of 84.4% of the ex-
pected. Examinationof the hands and feet revealed re-
ticulate hyper and hypopigmented macules extending 
proximally from the dorsal surfaces of the fingers and 
toes to the wrists and ankles respectively, the skin tex-
ture was normal and there were no pits or breaks in the 
linear ridges of the palms. There were no similar lesions 
on other parts of the body. Systemic examination was
essentially normal, full blood count and urinalysis 
yielded no abnormality and biopsy of a hyperpigmented 
macule showed focal reticulated papillomatosis alternat-
ing with epidermal atrophy. There was basal hyperpig-
mentation with normal number of melanocytes and ab-
sence of melanin incontinence. (Figure 2)  Based on the 
typical clinical presentation and suggestive histologic 
finding a diagnosis of Dyschromatosissymmetrica-
hereditaria was made. The family was informed about 
the natural history of DSH and counselled on their ex-
pectations regarding treatment and resolution, and pa-
tient was given a yearly appointment 
Fig 1:  Mottled hyper- and 
hypopigmentation on the dorsa 






Fig 2: Photomicrograph of 
biopsied lesion from dorsum 











Dyschromatosis symmetrica hereditaria is a rare genetic 
disorder of skin pigmentation, which was initially 
thought to be a Japanese-specific genodermatoses. It is 
often shown to have an autosomal dominant pattern of 
inheritance4; however, there have been reports of auto-
somal recessive7 and sporadic cases5. The latter which is 
the mode seen in our index patient, with no known fam-
ily history of the condition. Mutations occur in the RNA
-specific adenosine deaminase gene (ADAR1), and more 
than 122 of such mutations in this gene have been r-
ported8.  It phenotypically presents as pinpoint or pea-
sized symmetrical mottled hypo- and hyperpigmented 
macules, typically in an acral distribution. There may be 
associated freckle-like macules on the face, extension of 
acral lesions proximally and lesions on the chest3,4. On-
set of DSH is usually in infancy and childhood, with 
progression and eventual stabilization prior to adoles-
cence and this lasts for life, however, Gaiewski9 re-
ported a late onset presentation, with acral lesions begin-
ning at the age of 26 years.  
 
A number of other reticulate pigmentary disorders exi t 
which must be differentiated from DSH, they include: 
dyschromatosis universalis hereditaria (DUH), which in 
contrast to DSH has a more widespread distribution; 
reticulate acropigmentation of Kitamura (RAK) which 
presents with mottled solely hyperpigmented lesions 
also on the dorsal extremities with associated palmar 
pits and breaks in dermatoglyphics; Dowling-Degos 
disease which has a similar clinical presentation with 
RAK, but lesions are found in the flexures and large 
body folds and Galli-Galli disease with a distinctive 
histologic finding of suprabasal acantholysis10. The typi-
cal histopathologic finding in DSH is, increased melanin 
pigment in the basal layer and throughout the epidermis 
in hyperpigmented lesions, and reduced or absent mela-
nin in hypopigmented lesions, all with normal number 
of melanocytes. In addition to the above findings our
patient also had epidermal atrophy which is not a dis-
tinctive feature of DSH, however Peng et al4 reported a 
case of DSH, howbeit with focal epidermal atrophy on 
histology, mutation analysis confirmed the diagnosis of 
DSH. Epidermal atrophy is more commonly found in 
acropigmentation of Kitamura (RAK), however, there is 
often an increase in the number of basal melanocytes 
(which was not observed in our patient’s histology) and 
the clinical picture is also different. DSH has been asso-
ciated with a number of disease entities, including 
dystonia, mental retardation, neurofibromatosis, seizur , 
autism, urticaria, mood disorder, β thalassemia and poly-
dactyly4,6,11 but none of these associations have been 
consistent. There was no similar or novel association in 
our patient. Treatment of DSH has included the use of 
topical steroids, pimerolimus, calcipotriol and Psoralen 
plus UVA (PUVA) all of which have not led to resolu-






In conclusion, this report has documented the existnce 
of dyschromatosis symmetrica hereditariain Nigeria; a 
condition which may be misdiagnosed as vitiligo, lead-
ing to the unnecessary use of potentially harmful and/or 
expensive therapies by clinicians5,7. 
It is hoped that our report has increased the list of differ-
entials of pigmentary disorders in our environment, 
where most hypopigmentary lesions are often consid-
ered to be leprosy by the lay public. (a condition associ-
ated with a high degree of stigmatization). We have lso 
highlighted the need for follow-up of children with DSH 
for the future documentation of known or novel associa-
tions 
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